G
Genprex D
D
GNPX
9.61000
USD
0.46
(5.03%)
مغلق
حجم التداول
12,243
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
9,651,573
الأخبار المقالات
العنوان: Genprex Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for largepatient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.